Loading asset research
AEON Biopharma Inc. Class A Common Stock
AEONNYSE · USD · StocksQuote as of · Exchange session not verified$0.327
+12.76%
Today
AEON
Loading 1D prices…
Market cap
$16.3M
Volume
30.8M
52w high
$1.4552w low
$0.177Company profile
AEON Biopharma Inc. Class A Common Stock
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
NYSE
Display currency
USD
Location
Irvine, CA, United States
Employees
8
Fiscal year end
1231
CIK
1837607
Session & valuation
Open$0.298
Previous close$0.29
Day high$0.38
Day low$0.29
30-day avg. volume11M
Outstanding shares49.9M
Diluted EPS-$3.95
Latest annual period
P/E (trailing)-0.08
P/E (forward)-1.21
Price / book-0.56
Beta0.65
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BIVIBioVie Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.05 | +1.05% | Unrated |
| PDSBPDS Biotechnology Corporation Common Stock | $16.5M | $0.00 | — | -$0.74 | -6.44% | Buy |
| CTXRCitius Pharmaceuticals Inc. Common Stock | $15.9M | $7.1M | -695.59% | -$1.64 | -0.68% | Hold |
| RKTORocket One Inc. Common Stock | $15.9M | $0.00 | — | -$0.90 | -0.62% | Buy |
| ENLVEnlivex Ltd. Ordinary Shares | $16.8M | $0.00 | — | $25.48 | -3.16% | Buy |